These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
☒
Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the quarterly period ended
March 31, 2024
OR
☐
Transition Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the transition period from _____ to _____
Commission File Number.
001-33794
HILLENBRAND, INC.
(Exact name of registrant as specified in its charter)
Indiana
26-1342272
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
One Batesville Boulevard
Batesville,
Indiana
47006
(Address of principal executive offices)
(Zip Code)
(
812
)
931-5000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, without par value
HI
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Emerging growth company
☐
Non-accelerated filer
☐
Smaller reporting company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
The registrant had
70,195,438
shares of common stock, no par value per share, outstanding as of April 26, 2024.
Condensed Notes to Consolidated Financial Statements (Unaudited)
(
in millions, except share and per share data
)
1.
Background and Basis of Presentation
Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global industrial company that provides highly-engineered processing equipment and solutions to customers around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose, Shape What Matters for Tomorrow
TM
, we pursue excellence, collaboration, and innovation to shape solutions that best serve our people, our customers, and our communities. Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements.
On February 1, 2023, the Company completed the divestiture of its historical Batesville reportable operating segment (“Batesville”) to BL Memorial Partners, LLC, a Delaware limited liability company owned by funds affiliated with LongRange Capital, L.P., for $761.5, including an $11.5 subordinated note.
This divestiture represented a strategic shift in Hillenbrand’s business and qualified as a discontinued operation. Accordingly, the operating results and cash flows related to Batesville have been reflected as discontinued operations in the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for all periods presented. Unless otherwise noted, discussion within the condensed notes to the Consolidated Financial Statements relates to continuing operations only and excludes Batesville. See Note 4 for additional information on this divestiture.
The Company is providing, and will continue to provide, certain transition services to Batesville for applicable fees that are not material to the Company’s consolidated financial position. The transition services vary in duration depending upon the type of service provided.
As a result of the divestiture, Hillenbrand is now composed of
two
reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. Advanced Process Solutions is a leading global provider of highly-engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions is a global leader in highly-engineered equipment, systems, and aftermarket parts and service for the plastic technology processing industry. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, hot runner systems, process control systems, mold bases and components, and maintenance, repair, and operating (“MRO”) supplies.
The Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include three subsidiaries where the Company’s ownership percentage is less than
100
%. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years refer to fiscal years.
These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2023, as filed with the SEC on November 15, 2023. In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the consolidated results of operations to be expected for the full fiscal year.
The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net revenue and expenses during the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, revenue recognition under the over time method, establishment of reserves related to credit losses, warranties, inventories, income taxes, litigation, and self-insurance.
The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2023.
Recently adopted accounting standards
In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2022-04,
Liabilities - Supplier Finance Programs (Subtopic 405-50); Disclosure of Supplier Finance Program Obligations
. ASU 2022-04 requires entities that use supplier finance programs to disclose information about the nature and potential magnitude of the programs, activity during the period, and changes from period to period. ASU 2022-04 does not affect the recognition, measurement, or consolidated financial statement presentation of obligations covered by supplier finance programs. The Company adopted ASU 2022-04 effective October 1, 2023. The adoption of ASU 2022-04 did not have a material effect on our Consolidated Financial Statements and related disclosures. See Note 6 for further details.
Recently issued accounting standards
In November 2023, the FASB issued ASU 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
. ASU 2023-07 requires additional disclosures pertaining to significant expenses and other items of an entity’s reportable operating segments. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 (fiscal 2025). Early adoption is permitted. The Company is currently evaluating the impact of ASU 2023-07 on the Consolidated Financial Statements.
In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures
, which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024 (fiscal 2026). The Company is currently evaluating the impact of ASU 2023-09 on the Consolidated Financial Statements.
No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.
3.
Revenue Recognition
Net revenue includes gross revenue less sales discounts and sales incentives, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances based upon historical experience.
Contract balances
The balance in receivables from long-term manufacturing contracts at March 31, 2024 and September 30, 2023, was $
329.7
and $
260.2
, respectively. The change was driven by the impact of net revenue recognized prior to billings to customers. The balance in the liabilities from long-term manufacturing contracts and advances at March 31, 2024 and September 30, 2023, was $
369.8
and $
388.5
, respectively, and consists primarily of cash payments received in advance of satisfying performance obligations. The net revenue recognized for the six months ended March 31, 2024 and 2023, related to liabilities from long-term manufacturing contracts and advances as of September 30, 2023 and 2022, was $
209.7
and $
147.1
, respectively. During the three and six months ended March 31, 2024 and 2023, the adjustments related to performance obligations satisfied in previous periods were immaterial.
Transaction price allocated to the remaining performance obligations
As of March 31, 2024, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Part I, Item 2 of this Quarterly Report on Form 10-Q, was $
2,106.9
. Approximately
84
% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years.
The following tables present net revenue by timing of transfer:
Three Months Ended March 31, 2024
Six Months Ended March 31, 2024
Advanced Process Solutions
Molding Technology Solutions
Total
Advanced Process Solutions
Molding Technology Solutions
Total
Timing of transfer
Point in time
$
281.6
$
205.2
$
486.8
$
559.7
$
391.7
$
951.4
Over time
277.6
20.9
298.5
567.8
39.4
607.2
Total
$
559.2
$
226.1
$
785.3
$
1,127.5
$
431.1
$
1,558.6
Three Months Ended March 31, 2023
Six Months Ended March 31, 2023
Advanced Process Solutions
Molding Technology Solutions
Total
Advanced Process Solutions
Molding Technology Solutions
Total
Timing of transfer
Point in time
$
221.6
$
226.1
$
447.7
$
441.8
$
456.1
$
897.9
Over time
208.9
34.3
243.2
401.5
47.2
448.7
Total
$
430.5
$
260.4
$
690.9
$
843.3
$
503.3
$
1,346.6
4.
Divestiture
As previously described, on February 1, 2023, the Company completed the divestiture of Batesville to BL Memorial Partners, LLC, a Delaware limited liability company owned by funds affiliated with LongRange Capital, L.P., for $
761.5
, including an $
11.5
subordinated note. At closing, after the applicable adjustments, the Company received $
698.0
in pre-tax cash proceeds, including an adjustment for cash on hand acquired from the Company, and the previously mentioned subordinated note.
Certain indirect corporate costs included within operating expenses in the Consolidated Statements of Operations that were previously allocated to Batesville do not qualify for classification within discontinued operations and are now reported as operating expenses in continuing operations within corporate expenses. In addition, costs directly attributable to the Batesville reportable operating segment divestiture have been reflected in discontinued operations. As a result, income before income taxes of the historical Batesville reportable operating segment decreased $14.4 and $17.9 for the three and six months ended March 31, 2023, respectively.
Discontinued operations
Components of amounts reflected in the Consolidated Statements of Operations related to discontinued operations are presented in the table, as follows:
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Net revenue
$
—
$
57.7
$
—
$
213.7
Cost of goods sold
—
38.5
—
142.2
Gross profit
—
19.2
—
71.5
Operating expenses
—
23.1
0.3
44.0
(Loss) income from discontinued operations before income taxes
—
(
3.9
)
(
0.3
)
27.5
Income tax (benefit) expense
—
(
2.4
)
—
8.0
(Loss) income from discontinued operations (net of income tax (benefit) expense)
—
(
1.5
)
(
0.3
)
19.5
Gain on divestiture of discontinued operations (net of income tax expense of $145.1)
Acquisition of Schenck Process Food and Performance Materials Business
On September 1, 2023, the Company completed its acquisition of Schenck Process Food and Performance Materials (“FPM”) for $
763.3
, net of cash acquired, which consisted of $
748.7
in consideration paid at the acquisition date, plus contingent consideration of $
14.6
. The contingent consideration of $
14.6
reflects the estimated fair value, as of the date of acquisition, of contingent future cash payments based on the value of certain research and development tax credits that were generated by FPM prior to the acquisition date. The value of these credits, and therefore the payment of the contingent consideration, is subject to audit by the tax authorities and to the closing of the statute of limitations for the year in which the tax credits are fully utilized, the timing of which is not able to be determined at this time, but we expect to extend several years. We estimated the fair value based on a third-party evaluation of the research and development tax credits completed during the six months ended March 31, 2024 and do not expect the amount to exceed $
14.6
. The purchase price is also subject to certain customary post-closing adjustments. The Company used available borrowings under its multi-currency revolving credit facility (the “Facility”) to fund the cash consideration portion of this acquisition.
Headquartered in Kansas City, Missouri, FPM specializes in the design, manufacturing, and service of feeding, filtration, baking, and material handling technologies and systems that are highly complementary to the equipment and solutions offered in our Advanced Process Solutions reportable operating segment. The results of FPM since the date of the acquisition are included in the Advanced Process Solutions reportable operating segment.
Preliminary purchase price allocation and other items
The Company used the services of an independent valuation consultant, along with estimates and assumptions determined by management, to estimate the fair value of the assets acquired and liabilities assumed. The preliminary allocation of the purchase price was based on an evaluation of the appropriate fair values and represents management’s best estimate based on available data. The purchase price allocation of the assets acquired and liabilities assumed is preliminary until the contractual post-closing adjustments are finalized, and the measurement period allowed for under Accounting Standards Codification (“ASC 805”),
Business Combinations
(“ASC 805”) has closed. The final determination of the fair value of assets acquired and liabilities assumed will be completed within the one-year measurement period as allowed by ASC 805. Changes during the measurement period could be material.
Based on current fair value estimates, the preliminary purchase price for FPM has been allocated to individual assets acquired and liabilities assumed as of the acquisition date:
Receivables from long-term manufacturing contracts
22.4
—
22.4
Inventories
64.8
(
3.9
)
60.9
Prepaid expenses and other current assets
10.3
(
0.1
)
10.2
Property, plant, and equipment
27.3
14.3
41.6
Operating lease right-of-use assets
11.0
3.1
14.1
Intangible assets
338.0
1.4
339.4
Goodwill
476.5
1.5
478.0
Other non-current assets
2.7
4.1
6.8
Total assets acquired
1,035.5
18.8
1,054.3
Liabilities assumed:
Trade accounts payable
59.4
(
2.4
)
57.0
Liabilities from long-term manufacturing contracts
86.6
—
86.6
Accrued compensation
13.5
—
13.5
Other current liabilities
45.7
1.4
47.1
Operating lease liabilities
9.5
—
9.5
Deferred income taxes
69.0
4.2
73.2
Other non-current liabilities
3.1
1.0
4.1
Total liabilities assumed
286.8
4.2
291.0
Net assets acquired
$
748.7
$
14.6
$
763.3
Measurement period adjustments
The preliminary purchase price allocation was based upon a preliminary valuation, and the Company’s estimates and assumptions are subject to change within the measurement period (defined as one year following the acquisition date). As a result of further refining its estimates and assumptions since the date of the acquisition, the Company recorded measurement period adjustments to the initial opening balance sheet as shown in the table above. Adjustments were primarily made to inventories, property, plant, and equipment, operating lease right-of-use assets, other non-current assets, and deferred income taxes. There were no measurement period adjustments materially impacting earnings that would have been recorded in previous reporting periods if the adjustments had been recognized as of the acquisition date.
Intangible assets identified
The preliminary purchase price allocation included $
339.4
of acquired identifiable intangible assets. Intangible assets consist of FPM’s technology, Baker Perkins trade name, and customer relationships and will be amortized on a straight-line basis over the respective estimated periods for which the intangible assets will provide economic benefit to the Company. The determination of the useful lives is based upon various industry studies, historical acquisition experience, degree of stability in the current FPM customer base, economic factors, and expected future cash flows of the Company following the acquisition of FPM. The technology and Baker Perkins trade name were valued using the relief-from-royalty method of the income approach. Customer relationships were valued using the multi-period excess earnings method of the income approach. Significant assumptions used in the valuations included FPM’s future cash flow projections, which were based on estimates used to price the FPM acquisition, discount rates that were benchmarked with reference to the implied rate of return to the Company’s pricing model, and the applicable weighted-average cost of capital (
12
%).
The preliminary amounts allocated to intangible assets are as follows:
Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The factors contributing to the recognition of goodwill were based on strategic benefits that are expected to be realized from the acquisition. None of the goodwill is expected to be deductible for income tax purposes.
The working capital assets and liabilities, as well as the property, plant, and equipment acquired, were valued using Level 2 inputs, which included data points that are observable, such as definitive sales agreements, appraisals or established market values of comparable assets (market approach). Identifiable intangible assets were valued using Level 3 inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs in isolation would result in a significantly lower (higher) fair value measurement. Management used a third-party valuation firm to assist in the determination of the preliminary purchase accounting fair values, specifically those considered Level 3 measurements. Management oversees the third-party valuation firm to ensure that the transaction-specific assumptions are appropriate for the Company.
Impact on results of operations
The results of FPM’s operations have been included in Hillenbrand’s Consolidated Financial Statements since the September 1,
2023 acquisition date. The following table provides the results of operations for FPM included in Hillenbrand’s Consolidated
Statement of Operations:
Three Months Ended March 31, 2024
Six Months Ended March 31, 2024
Net revenue
$
126.0
$
272.0
Income from continuing operations before income taxes
12.7
26.8
During the six months ended March 31, 2024, the Company incurred $
0.4
in acquisition expenses related to the FPM acquisition, which are included in operating expenses in the Consolidated Statement of Operations.
Acquisition of Peerless Food Equipment
On December 1, 2022, the Company completed the acquisition of the Peerless Food Equipment division (“Peerless”) of Illinois Tool Works Inc. for a purchase price of $
59.2
, including cash acquired, using available borrowings under the Facility. Headquartered in Sidney, Ohio, Peerless is a premier supplier of industrial food processing equipment.
The acquisition of Peerless increased the Company's scale in the food end market, and combining Peerless’ highly complementary equipment and solutions with existing Advanced Process Solutions reportable operating segment technologies now allows the Company to deliver more comprehensive solutions to its customers. The results of Peerless since the date of acquisition are included in the Advanced Process Solutions reportable operating segment.
Acquisition of LINXIS Group SAS
On October 6, 2022, the Company completed the acquisition of LINXIS Group SAS (“Linxis”) from IBERIS INTERNATIONAL S.À R.L, an affiliate of IK Partners, and additional sellers (collectively, the “Sellers”). As a result of the acquisition, the Company acquired from the Sellers all of the issued and outstanding securities of Linxis, and Linxis became a wholly owned subsidiary of the Company for total aggregate consideration of $
590.8
(€
596.2
) in cash, reflecting an approximate enterprise value of $
566.8
(€
572.0
) plus cash acquired at closing. The Company used available borrowings under the Facility to fund this acquisition.
Linxis has six market-leading brands – Bakon, Diosna, Shaffer, Shick Esteve, Unifiller, and VMI – that serve customers in over one hundred countries. With a global manufacturing, sales and service footprint, Linxis specializes in the design, manufacturing, and service of dosing, kneading, mixing, granulating, drying, and coating technologies. The purchase price allocation was finalized during the year ended September 30, 2023. The results of Linxis since the date of acquisition are included in the Advanced Process Solutions reportable operating segment.
Supplemental Pro Forma Information
The supplemental pro forma financial information presented below for the historical period is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the FPM acquisition had been completed on the date indicated, do not reflect synergies that might have been achieved, and are not indicative of future results of operations or financial position. The pro forma adjustments are based upon currently available information and certain assumptions that Hillenbrand believes are reasonable under the circumstances.
The supplemental pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the acquisition of FPM had occurred on October 1, 2022, to give effect to certain events that Hillenbrand believes to be directly attributable to the acquisitions. These pro forma adjustments primarily include:
•
an increase to depreciation and amortization expense that would have been recognized due to acquired tangible and intangible assets;
•
an adjustment to remove business acquisition and integration costs and inventory step-up costs during the three and six months ended March 31, 2023, as these costs are non-recurring in nature and would not have a continuing effect on Hillenbrand’s results of operations; and
•
the related income tax effects of the adjustments noted above.
The supplemental pro forma financial information for the historical period presented is as follows:
Three Months Ended March 31, 2023
Six Months Ended March 31, 2023
Net revenue
$
801.0
$
1,614.5
Income from continuing operations attributable to Hillenbrand
19.8
40.6
Income from continuing operations attributable to Hillenbrand — per share of common stock:
Basic earnings per share from continuing operations
$
0.28
$
0.58
Diluted earnings per share from continuing operations
6.
Supplemental Consolidated Balance Sheet Information
March 31,
2024
September 30,
2023
Allowance for credit losses
$
9.6
$
10.1
Warranty reserves
$
37.2
$
35.8
Accumulated depreciation on property, plant, and equipment
$
256.0
$
226.7
Inventories, net:
Raw materials and components
$
276.0
$
285.2
Work in process
135.9
135.0
Finished goods
177.0
172.4
Total inventories, net
$
588.9
$
592.6
Other current liabilities:
Income tax payable
$
31.8
$
72.8
Other current liabilities
221.9
258.9
Total other current liabilities
$
253.7
$
331.7
The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:
March 31, 2024
March 31, 2023
Cash and cash equivalents
$
224.4
$
315.1
Short-term restricted cash included in other current assets
0.8
0.8
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows
$
225.2
$
315.9
Supplier Finance Program
The Company has agreements with third-party financial institutions to facilitate supply chain finance (“SCF”) programs. The SCF programs allow qualifying suppliers to sell their receivables, on an invoice level at the selection of the supplier, from the Company to the financial institutions and negotiate their outstanding receivable arrangements and associated fees directly with the financial institutions. Hillenbrand is not party to the agreements between the supplier and the financial institutions. The supplier invoices that have been confirmed as valid under the SCF programs require payment in full by the financial institutions to the supplier by the original maturity date of the invoice, or discounted payment at an earlier date as agreed upon with the supplier. The Company’s obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted by a supplier’s participation in the SCF programs.
All outstanding amounts related to suppliers participating in the SCF programs are recorded upon confirmation with the third-party financial institutions in trade accounts payable in the Consolidated Balance Sheets, and associated payments are included in cash used in operating activities in the Consolidated Statements of Cash Flows. The Company’s outstanding obligations included in trade accounts payable as of March 31, 2024 and September 30, 2023, were $
28.9
and $
29.1
, respectively.
Trade Receivables Financing
During the six months ended March 31, 2024, the Company executed an amendment of its trade receivables financing arrangement (as amended, the “Amended Arrangement”) with a financial institution. In accordance with ASC 869,
Transfers and Servicing
, this Amended Arrangement is deemed a true sale, as the Company retains no rights or interest and has no obligations with respect to the trade receivables. The Company had proceeds from the sale of trade receivables under the Amended Arrangement of $
66.4
and $
127.7
, respectively, for the three and six months ended March 31, 2024 ($
0.0
for the three and six months ended March 31, 2023). As of March 31, 2024 and September 30, 2023, trade receivables in the amount
of $
28.8
and $
0.0
, respectively, were sold to the financial institution and are not reflected in the trade receivables in the Consolidated Balance Sheets.
7.
Leases
For the three and six months ended March 31, 2024 and 2023, the Company recognized $
8.1
and $
16.6
, and $
8.1
and $
15.2
of operating lease expense, respectively, including short-term lease expense and variable lease costs, which were immaterial in all periods. The Company’s finance leases were insignificant as of March 31, 2024 and September 30, 2023.
The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases:
March 31, 2024
September 30, 2023
Operating lease right-of-use assets, net
$
112.0
$
111.3
Other current liabilities
19.9
18.6
Operating lease liabilities
85.3
88.1
Total operating lease liabilities
$
105.2
$
106.7
Weighted-average remaining lease term (in years)
6.7
7.1
Weighted-average discount rate
4.0
%
3.8
%
As of March 31, 2024, the maturities of the Company’s operating lease liabilities were as follows:
2024 (excluding the six months ended March 31, 2024)
$
12.4
2025
22.1
2026
18.1
2027
15.1
2028
13.5
Thereafter
37.7
Total lease payments
118.9
Less: imputed interest
(
13.7
)
Total present value of lease payments
$
105.2
Supplemental Consolidated Statements of Cash Flow information related to the Company’s operating leases is as follows:
Six Months Ended March 31,
2024
2023
Cash paid for amounts included in the measurement of operating lease liabilities
$
13.7
$
10.8
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities
7.2
8.1
Operating leases acquired in acquisitions
3.0
15.0
8.
Intangible Assets and Goodwill
Intangible Assets
Intangible assets are stated at the lower of cost or fair value. Intangible assets are amortized on a straight-line basis over periods ranging from
three
to
21
years, representing the period over which the Company expects to receive future economic benefits from these assets. The Company assesses the carrying value of indefinite-lived trade names annually, or more often if events or changes in circumstances indicate there may be an impairment.
The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of:
March 31, 2024
September 30, 2023
Cost
Accumulated
Amortization
Cost
Accumulated
Amortization
Finite-lived assets:
Customer relationships
$
1,294.8
$
(
331.4
)
$
1,290.2
$
(
291.4
)
Technology, including patents
190.6
(
91.5
)
192.3
(
83.1
)
Software
54.5
(
35.9
)
41.7
(
31.7
)
Trade names
50.7
(
7.5
)
41.9
(
4.2
)
1,590.6
(
466.3
)
1,566.1
(
410.4
)
Indefinite-lived assets:
Trade names
222.5
—
221.4
—
Total
$
1,813.1
$
(
466.3
)
$
1,787.5
$
(
410.4
)
Finite-lived intangible assets, net of $
717.2
and $
740.0
are included in the Advanced Process Solutions reportable operating segment at March 31, 2024 and September 30, 2023, respectively. Indefinite-lived intangible assets of $
110.4
and $
109.3
are included in the Advanced Process Solutions reportable operating segment at March 31, 2024 and September 30, 2023, respectively. The net change in intangible assets in the Advanced Process Solutions reportable operating segment during the six months ended March 31, 2024, was driven primarily by acquisition measurement period adjustments, amortization, and foreign currency adjustments. Finite-lived intangible assets, net of $
399.5
and $
412.9
are included in the Molding Technology Solutions reportable operating segment at March 31, 2024 and September 30, 2023, respectively. Indefinite-lived intangible assets of $
112.1
are included in the Molding Technology Solutions reportable operating segment at both March 31, 2024 and September 30, 2023. The net change in intangible assets in the Molding Technology Solutions reportable operating segment during the six months ended March 31, 2024, was driven primarily by amortization and foreign currency adjustments.
Goodwill
Goodwill is not amortized but is subject to annual impairment tests. Goodwill has been assigned to reporting units within the reportable operating segments. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment. Impairment testing is performed at a reporting unit level.
The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the six months ended March 31, 2024:
Advanced Process Solutions
Molding Technology Solutions
Total
Balance as of September 30, 2023
$
1,394.9
$
633.2
$
2,028.1
Acquisition measurement period adjustments
1.8
—
1.8
Foreign currency adjustments
11.0
3.6
14.6
Balance as of March 31, 2024
$
1,407.7
$
636.8
$
2,044.5
During the three and six months ended March 31, 2024 and 2023, the Company did not observe any triggering events or substantive changes in circumstances requiring the need for an interim impairment assessment.
The following table summarizes Hillenbrand’s current and long-term debt as of:
March 31,
2024
September 30,
2023
$
1,000
revolving credit facility (excluding outstanding letters of credit)
$
112.2
$
505.1
$
200
term loan
187.5
192.5
€
185
term loan
194.5
195.0
$
500
senior unsecured notes
(1)
494.1
—
$
400
senior unsecured notes
(2)
398.6
398.0
$
375
senior unsecured notes
(3)
373.2
372.9
$
350
senior unsecured notes
(4)
346.9
346.6
Total debt
2,107.0
2,010.1
Less: current portion
20.0
19.7
Total long-term debt
$
2,087.0
$
1,990.4
(1)
Includes unamortized debt issuance costs of $
5.9
at March 31, 2024.
(2)
Includes unamortized debt issuance costs of $
1.4
and $
2.0
at March 31, 2024 and September 30, 2023, respectively.
(3)
Includes unamortized debt issuance costs of $
1.6
and $
1.8
at March 31, 2024 and September 30, 2023, respectively.
(4)
Includes unamortized debt issuance costs of $
3.1
and $
3.4
at March 31, 2024 and September 30, 2023, respectively.
$
500.0
senior unsecured notes
On February 14, 2024, the Company issued $
500.0
of senior unsecured notes due February 2029 (the “2024 Notes”). The 2024 Notes were issued at par value and bear interest at a fixed rate of
6.25
% per year, payable semi-annually in arrears beginning August 2024. Deferred financing costs associated with the 2024 Notes of $
6.2
are being amortized to interest expense on a straight-line basis (which approximates the effective interest method) over the term of the 2024 Notes. The 2024 Notes are unsecured unsubordinated obligations of the Company and rank equally in right of payment with all other existing and future unsubordinated obligations.
Subject to certain limitations, in the event of a change of control repurchase event (as defined in the 2024 Notes Indenture), the Company will be required to make an offer to purchase the 2024 Notes at a price equal to
101
% of the principal amount of the 2024 Notes, plus any accrued and unpaid interest to, but excluding, the date of repurchase. The Company may redeem the 2024 Notes at any time in whole, or from time to time in part, prior to February 15, 2026, at its option at the “make-whole” redemption price, as described in the 2024 Notes. The Company may also redeem the 2024 Notes at any time in whole, or from time to time in part, on or after February 15 of the relevant year listed, as follows: 2026 at a redemption price of
103.125
%; 2027 at a redemption price of
101.5625
%; and 2028 and thereafter at a redemption price of
100.000
%. At any time prior to February 15, 2026, the Company may redeem up to
40
% of the aggregate principal amount of the 2024 Notes with the proceeds of one or more Equity Offerings (as defined in the 2024 Notes Indenture) at a redemption price of
106.250
% of the principal amount of the 2024 Notes being redeemed. In each of the above cases, the Company will also pay any accrued and unpaid interest to, but excluding, the applicable redemption date.
Other borrowing activity
As of March 31, 2024, the Company had $
19.5
in outstanding letters of credit issued and $
868.3
of borrowing capacity under the Facility, of which $
500.5
was immediately available based on the Company’s most restrictive covenant. The weighted-average interest rates on borrowings under the Facility were
6.02
% and
5.91
% for the three and six months ended March 31, 2024, respectively, and
3.12
% and
2.53
% for the three and six months ended March 31, 2023, respectively. The weighted average facility fee on the Facility was
0.23
% and
0.21
% for the three and six months ended March 31, 2024, respectively, and
0.20
% and
0.16
% for the three and six months ended March 31, 2023, respectively. The weighted-average interest rate on the $
200
term loan was
7.19
% and
7.08
% for the three and six months ended March 31, 2024, respectively, and
5.99
% and
5.84
% for the three and six months ended March 31, 2023, respectively. The weighted-average interest rate on the €
185
term loan was
5.59
% and
5.60
% for the three and six months ended March 31, 2024, respectively. There were
no
borrowings on the €
185
term loan for the three and six months ended March 31, 2023.
Remaining unamortized deferred financing costs related to the Facility, $
200
term loan and €
185
term loan were $
5.2
in aggregate, as of March 31, 2024, and are being amortized to interest expense over the remaining term of these agreements.
In the normal course of business, the Company provides, primarily to certain customers, bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of March 31, 2024 and September 30, 2023, the Company had credit arrangements totaling $
588.7
and $
587.9
, respectively, under which $
361.1
and $
326.9
, respectively, were used for guarantees. These arrangements include the Company’s Syndicated L/G Facility Agreement (“L/G Facility”) and other ancillary credit facilities. Remaining unamortized deferred financing costs related to the L/G Facility were $
1.4
and $
1.6
as of March 31, 2024 and September 30, 2023, respectively, and are being amortized to interest expense over the remaining term of the agreement.
As of March 31, 2024, Hillenbrand was in compliance with all covenants contained in the foregoing agreements and credit instruments, and there were no events of default.
10.
Retirement Benefits
Defined Benefit Plans
Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows:
U.S. Pension Benefits
Non-U.S. Pension Benefits
Three Months Ended March 31,
Three Months Ended March 31,
2024
2023
2024
2023
Service costs
$
—
$
—
$
0.5
$
0.5
Interest costs
2.7
2.8
1.1
1.0
Expected return on plan assets
(
2.8
)
(
3.4
)
(
0.4
)
(
0.2
)
Amortization of net loss (gain)
—
0.1
(
0.1
)
(
0.2
)
Net periodic pension (benefit) cost
$
(
0.1
)
$
(
0.5
)
$
1.1
$
1.1
U.S. Pension Benefits
Non-U.S. Pension Benefits
Six Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Service costs
$
—
$
—
$
1.0
$
1.0
Interest costs
4.7
5.6
2.2
1.9
Expected return on plan assets
(
5.5
)
(
6.8
)
(
0.8
)
(
0.5
)
Amortization of net loss (gain)
0.1
0.2
(
0.3
)
(
0.4
)
Settlement charge
8.3
—
—
—
Net periodic pension cost (benefit)
$
7.6
$
(
1.0
)
$
2.1
$
2.0
On July 18, 2023, we announced an offer to provide former employees who are participants in the Company’s U.S. defined benefit pension plan (the “Plan”) the opportunity to elect a lump sum distribution of their earned Plan benefits. The Plan’s fiduciaries made lump sum payments to electing eligible participants in December 2023, funded by the existing assets in the Plan. As a result, the Company recorded a non-cash settlement pre-tax charge of $
8.3
during the six months ended March 31, 2024.
In April 2024, the remaining assets of the Plan were used to purchase annuities to support the remaining obligation, resulting in the termination and liquidation of the Plan.
Defined Contribution Plans
Expenses related to the Company’s defined contribution plans were $
2.5
and $
5.4
for the three and six months ended March 31, 2024, respectively, and $
2.5
and $
5.4
for the three and six months ended March 31, 2023, respectively.
The effective tax rates for the three months ended March 31, 2024 and 2023 were
32.8
% and
50.0
%, respectively.
The decrease in the effective tax rate was primarily driven by a decrease in the tax accrual on unrepatriated earnings, a favorable currency fluctuation affecting the valuation of certain deferred tax liabilities, and a non-recurring prior year tax, partially offset by a reduced discrete tax benefit for equity compensation as compared to the prior period.
The effective tax rates for the six months ended March 31, 2024 and 2023 were
33.6
% and
34.2
%, respectively. The decrease in the effective tax rate was primarily driven by a decrease in the tax accrual on unrepatriated earnings in the current period and
a non-recurring prior year tax
, partially offset by discrete tax benefits recognized in the prior period as a result of the approval of the incentive tax rate for certain operations located in China, and a reduced discrete tax benefit for equity compensation as compared to the prior period.
12.
Earnings per share
The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective Consolidated Balance Sheet date. Potential dilutive effects, representing approximately
440,000
and
350,000
shares at March 31, 2024 and 2023, respectively, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future.
Three Months Ended
March 31,
Six Months Ended
March 31,
2024
2023
2024
2023
Income from continuing operations
$
8.6
$
24.1
$
28.1
$
50.9
Less: Net income attributable to noncontrolling interests
2.5
0.8
4.5
3.1
Income from continuing operations attributable to Hillenbrand
$
6.1
$
23.3
$
23.6
$
47.8
Weighted-average shares outstanding (basic - in millions)
70.4
69.7
70.4
69.6
Effect of dilutive stock options and other unvested equity awards (in millions)
0.3
0.4
0.2
0.3
Weighted-average shares outstanding (diluted - in millions)
70.7
70.1
70.6
69.9
Basic earnings per share from continuing operations attributable to Hillenbrand
$
0.09
$
0.33
$
0.34
$
0.69
Diluted earnings per share from continuing operations attributable to Hillenbrand
$
0.09
$
0.33
$
0.34
$
0.68
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)
Affected Line in the Consolidated Statement of Operations:
Net revenue
$
—
$
—
$
0.1
$
0.1
Cost of goods sold
—
—
(
0.9
)
(
0.9
)
Operating expenses
(
0.2
)
—
0.5
0.3
Gain on divestiture of discontinued operations (net of income tax expense)
(
1.4
)
(
0.1
)
—
(
1.5
)
Total before tax
$
(
1.6
)
$
(
0.1
)
$
(
0.3
)
(
2.0
)
Tax expense
0.8
Total reclassifications for the period, net of tax
$
(
1.2
)
Six Months Ended March 31, 2023
Amortization of Pension and
Postretirement
(1)
(Gain) Loss on
Net Gain
Recognized
Prior Service Costs
Recognized
Derivative
Instruments
Total
Affected Line in the Consolidated Statement of Operations:
Cost of goods sold
—
—
(
1.0
)
(
1.0
)
Operating expenses
(
0.3
)
—
1.0
0.7
Gain on divestiture of discontinued operations (net of income tax expense)
(
1.4
)
(
0.1
)
—
(
1.5
)
Total before tax
$
(
1.7
)
$
(
0.1
)
$
—
(
1.8
)
Tax expense
0.7
Total reclassifications for the period, net of tax
$
(
1.1
)
(1)
These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 10).
14.
Share-Based Compensation
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Share-based compensation costs
$
4.7
$
4.5
$
9.9
$
9.1
Less impact of income taxes
1.1
1.0
2.3
2.1
Share-based compensation costs, net of tax
$
3.6
$
3.5
$
7.6
$
7.0
The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value, as well as time-based awards. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a
three-year
period to the respective total shareholder returns of companies in a designated stock index. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period. For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants.
During the six months ended March 31, 2024, the Company made the following grants:
Number of
Units
Time-based stock awards
314,710
Performance-based stock awards (maximum that can be earned)
475,057
The Company’s time-based stock awards and performance-based stock awards granted during the six months ended March 31, 2024 had weighted-average grant date fair values of $
39.26
and $
41.45
, respectively. Included in the performance-based stock awards granted during the six months ended March 31, 2024 are
276,700
units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above. These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.
15.
Commitments and Contingencies
From time to time, Hillenbrand is involved in claims, lawsuits, and government proceedings relating to its operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment-related, and other matters. The ultimate outcome of any claims, lawsuits, and proceedings cannot be predicted with certainty. An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters. If a loss is not considered probable and/or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred. Legal fees associated with claims and lawsuits are generally expensed as incurred.
Claims covered by insurance have in most instances deductibles and self-funded retentions up to $
0.5
per occurrence or per claim, depending upon the type of coverage and policy period. For auto, workers’ compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary often provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses. For all other types of claims, reserves are established when payment is considered probable and are based upon advice from internal and external counsel and historical settlement information for such claims.
The liabilities recorded represent the best estimate of costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates.
At March 31, 2024 and September 30, 2023, the Company had $
11.2
and $
5.1
, respectively, included in other current liabilities on the Consolidated Balance Sheets, related to a discrete commercial dispute stemming from a contract entered into with a Molding Technology Solutions’ customer prior to the Company’s acquisition of the Molding Technology Solutions reportable operating segment.
16.
Fair Value Measurements
Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels:
Level 1:
Inputs are quoted prices in active markets for identical assets or liabilities.
Level 2:
Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly.
Level 3:
Inputs are unobservable for the asset or liability.
See the section below titled “Valuation techniques” for further discussion of how Hillenbrand determines fair value for certain assets and liabilities.
Carrying Value at March 31, 2024
Fair Value at March 31, 2024
Using Inputs Considered as:
Level 1
Level 2
Level 3
Assets:
Cash and cash equivalents
$
224.4
$
224.4
$
—
$
—
Restricted cash
0.8
0.8
—
—
Investments in rabbi trust
4.2
4.2
—
—
Derivative instruments
1.1
—
1.1
—
Liabilities:
Facility
112.2
—
112.2
—
$200 term loan
187.5
—
187.5
—
€
185 term loan
194.5
—
194.5
—
$350 senior unsecured notes
350.0
303.3
—
—
$400 senior unsecured notes
400.0
399.5
—
—
$375 senior unsecured notes
374.8
368.7
—
—
$500 senior unsecured notes
500.0
504.4
—
—
Derivative instruments
1.1
—
1.1
—
Carrying Value at September 30, 2023
Fair Value at September 30, 2023
Using Inputs Considered as:
Level 1
Level 2
Level 3
Assets:
Cash and cash equivalents
$
242.9
$
242.9
$
—
$
—
Restricted cash
7.3
7.3
—
—
Investments in rabbi trust
3.3
3.3
—
—
Derivative instruments
1.5
—
1.5
—
Liabilities:
Facility
505.1
—
505.1
—
$200 term loan
192.5
—
192.5
—
€
185 term loan
195.0
—
195.0
—
$350 senior unsecured notes
350.0
281.6
—
—
$400 senior unsecured notes
400.0
395.1
—
—
$375 senior unsecured notes
374.7
355.0
—
—
Derivative instruments
1.7
—
1.7
—
Valuation techniques
•
Cash and cash equivalents, restricted cash, and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments.
•
The Company estimates the fair value of foreign currency derivatives using industry accepted models. The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility. These inputs were obtained from pricing services, broker quotes, and other sources.
•
The fair values of the Facility, $200 term loan, and €185 term loan were estimated based on internally-developed models using current market interest rate data for similar issues, as there is no active market for the Facility, $200 term loan, and €185 term loan, and therefore, are classified within Level 2 of the fair value hierarchy.
•
The fair values of the $350 senior unsecured notes, $400 senior unsecured notes, $375 senior unsecured notes, and $500 senior unsecured notes were based on quoted prices in active markets and are classified within Level 1 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments.
Derivative instruments
The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months. The aggregate notional value of derivatives was $
166.5
and $
164.6
at March 31, 2024 and September 30, 2023, respectively. The derivatives are recorded at fair value in other current assets and other current liabilities in the Consolidated Balance Sheets.
17.
Segment and Geographical Information
As previously described, on February 1, 2023, the Company completed the divestiture of Batesville. The operating results and cash flows for Batesville have been classified as discontinued operations within the Consolidated Financial Statements for all periods presented.
Hillenbrand is now composed of
two
reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. The Company’s reportable operating segments maintain separate financial information for which results of operations are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance.
The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs. Corporate provides management and administrative services to each reportable operating segment. These services include treasury management, human resources, legal, business development, information technology, tax compliance, global supply management, sustainability, and other public company support functions such as internal audit, investor relations, and financial reporting. With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable operating segments.
The following tables present financial information for the Company’s reportable operating segments and significant geographical locations:
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Net revenue
Advanced Process Solutions
$
559.2
$
430.5
$
1,127.5
$
843.3
Molding Technology Solutions
226.1
260.4
431.1
503.3
Total
$
785.3
$
690.9
$
1,558.6
$
1,346.6
Adjusted EBITDA
(1)
Advanced Process Solutions
$
100.8
$
73.2
$
196.8
$
144.5
Molding Technology Solutions
33.6
47.5
65.7
90.6
Corporate
(
11.8
)
(
12.1
)
(
25.8
)
(
25.2
)
Net revenue
(2)
United States
$
321.4
$
273.0
$
648.3
$
505.9
China
82.0
111.7
173.9
231.9
India
61.1
55.3
119.0
107.7
Germany
63.5
52.8
122.6
97.3
All other countries
257.3
198.1
494.8
403.8
Total
$
785.3
$
690.9
$
1,558.6
$
1,346.6
(1)
Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP measure used by management to measure segment performance and make operating decisions.
(2)
The Company attributes net revenue to a geography based upon the location of the end customer.
The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income:
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Adjusted EBITDA:
Advanced Process Solutions
$
100.8
$
73.2
$
196.8
$
144.5
Molding Technology Solutions
33.6
47.5
65.7
90.6
Corporate
(
11.8
)
(
12.1
)
(
25.8
)
(
25.2
)
Add:
Income (loss) from discontinued operations (net of income tax expense)
—
439.4
(
0.3
)
460.4
Less:
Interest expense, net
30.8
18.6
60.6
40.1
Income tax expense
4.2
24.1
14.2
26.4
Depreciation and amortization
41.2
31.0
80.0
62.0
Pension settlement charge
—
—
8.3
—
Business acquisition, divestiture, and integration costs
9.1
7.2
14.7
17.9
Inventory step-up (adjustment) charges
(
0.9
)
3.1
0.6
11.1
Restructuring and restructuring-related charges
23.5
0.5
24.1
1.5
Other non-recurring costs related to a discrete commercial dispute
6.1
—
6.1
—
Consolidated net income
$
8.6
$
463.5
$
27.8
$
511.3
18.
Restructuring
The following schedule details the restructuring charges by reportable operating segment and the classification of those charges in the Consolidated Statements of Operations.
Three Months Ended March 31, 2024
Three Months Ended March 31, 2023
Cost of goods sold
Operating expenses
Total
Cost of goods sold
Operating expenses
Total
Advanced Process Solutions
$
0.3
$
—
$
0.3
$
(
0.2
)
$
—
$
(
0.2
)
Molding Technology Solutions
9.2
12.8
22.0
—
0.5
0.5
Corporate
—
0.1
0.1
—
—
—
Total
$
9.5
$
12.9
$
22.4
$
(
0.2
)
$
0.5
$
0.3
Six Months Ended March 31, 2024
Six Months Ended March 31, 2023
Cost of goods sold
Operating expenses
Total
Cost of goods sold
Operating expenses
Total
Advanced Process Solutions
$
0.3
$
0.2
$
0.5
$
(
0.1
)
$
1.0
$
0.9
Molding Technology Solutions
9.2
12.8
22.0
—
0.5
0.5
Corporate
—
0.1
0.1
—
—
—
Total
$
9.5
$
13.1
$
22.6
$
(
0.1
)
$
1.5
$
1.4
During the three months ended March 31, 2024, the Company announced a program (the “Program”) to reduce costs and improve operational efficiency within the Molding Technology Solutions reportable operating segment. The Company expects that substantially all of these costs, which are primarily severance costs, will result in future cash expenditures, and we anticipate the majority of these cash expenditures to be paid in the next twelve months. The total liability related to the Program was $
20.3
as of March 31, 2024.
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
(financial amounts in millions, except share and per share data, throughout Management’s Discussion and Analysis)
FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS
Throughout this Quarterly Report on Form 10-Q, we make a number of “forward-looking statements,” that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995, and that are intended to be covered by the safe harbor provided under these sections. As the words imply, these are statements about future sales, earnings, cash flow, results of operations, uses of cash, financings, share repurchases, ability to meet deleveraging goals, and other measures of financial performance or potential future plans or events, strategies, objectives, beliefs, prospects, assumptions, expectations, and projected costs or savings or transactions of the Company that might or might not happen in the future, as contrasted with historical information. Forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand’s expectations and projections.
Accordingly, in this Quarterly Report on Form 10-Q, we may say something like:
“We
expect
that future net revenue associated with our reportable operating segments will be influenced by order backlog.”
That is a forward-looking statement, as indicated by the word “expect” and by the clear meaning of the sentence.
Other words that could indicate we are making forward-looking statements include:
intend
believe
plan
expect
may
goal
would
project
position
future
become
pursue
estimate
will
forecast
continue
could
anticipate
remain
likely
target
encourage
promise
improve
progress
potential
should
impact
strategy
This is not an exhaustive list, but is intended to give you an idea of how we try to identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking.
Here is the key point
:
Forward-looking statements are not guarantees of future performance or events, and actual results or events could differ materially from those set forth in any forward-looking statements.
Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: global market and economic conditions, including those related to the continued volatility in the financial markets; the risk of business disruptions associated with information technology, cyber-attacks, or catastrophic losses affecting infrastructure; increasing competition for highly skilled and talented workers, as well as labor shortages; closures or slowdowns and changes in labor costs and labor difficulties; uncertainty related to environmental regulation and industry standards, as well as physical risks of climate change; uncertainty related to environmental regulation, including the Securities and Exchange Commission’s (“SEC”) final climate rules and litigation regarding its enforceability; increased costs, poor quality, or unavailability of raw materials or certain outsourced services and supply chain disruptions; economic and financial conditions, including volatility in interest and exchange rates, commodity and equity prices and the value of financial assets; uncertainty in U.S. global trade policy; our level of international sales and operations; the impact of incurring significant amounts of indebtedness and any inability of the Company to respond to changes in its business or make future desirable acquisitions; the ability of the Company to comply with financial or other covenants in debt agreements; negative effects of acquisitions, including the Schenck Process Food and Performance Materials (“FPM”) business and Linxis Group SAS (“Linxis”) acquisitions, on the Company’s business, financial condition, results of operations and financial performance (including the ability of the Company to maintain relationships with its customers, suppliers, and others with whom it does business); the possibility that the anticipated benefits from acquisitions including the FPM and Linxis acquisitions cannot be realized by the Company in full or at all, or may take longer to realize than expected; risks that the integrations of FPM or Linxis or other acquired businesses disrupt current operations or pose potential difficulties in employee retention or otherwise affect financial or operating results; competition in the industries in which we operate, including on price; cyclical demand for industrial capital goods; the ability to recognize the benefits of any acquisition or divestiture, including potential synergies and cost savings or the failure of the Company or any acquired company to achieve its
plans and objectives generally; impairment charges to goodwill and other identifiable intangible assets; impacts of decreases in demand or changes in technological advances, laws, or regulation on the net revenues that we derive from the plastics industry; changes in food consumption patterns due to dietary trends, or economic conditions, or other reasons; our reliance upon employees, agents, and business partners to comply with laws in many countries and jurisdictions; the impact to the Company’s effective tax rate of changes in the mix of earnings or in tax laws and certain other tax-related matters; exposure to tax uncertainties and audits; involvement in claims, lawsuits, and governmental proceedings related to operations; uncertainty in the U.S. political and regulatory environment; adverse foreign currency fluctuations; labor disruptions; and the effect of certain provisions of the Company’s governing documents and Indiana law that could decrease the trading price of the Company’s common stock. Shareholders, potential investors, and other readers are urged to consider these risks and uncertainties in evaluating forward-looking statements and are cautioned not to place undue reliance on the forward-looking statements. For a more in-depth discussion of certain factors that could cause actual results to differ from those contained in forward-looking statements, see the discussion under the heading “Risk Factors” in Part I, Item 1A of Hillenbrand’s Form 10-K for the year ended September 30, 2023, filed with the SEC on November 15, 2023, as well as other risks and uncertainties detailed in our other filings with the SEC from time to time. Any forward-looking statement made in this Quarterly Report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update or revise any forward-looking statement, whether written or oral, made from time to time, whether as a result of new information, future developments or otherwise.
EXECUTIVE OVERVIEW
Hillenbrand (www.Hillenbrand.com) is a global industrial company that provides highly-engineered processing equipment and solutions to customers around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose, Shape What Matters for Tomorrow
TM
, we pursue excellence, collaboration, and innovation to shape solutions that best serve our people, our customers, and our communities. Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements.
During the three and six months ended March 31, 2024 and 2023, the following operational decisions and economic developments had an impact on our current and future cash flows, results of operations, and consolidated financial position.
Supply Chain and Inflation
While global supply chains have recently suffered from various headwinds, those supporting our products have generally remained intact, providing access to sufficient inventory of the key materials needed for manufacturing. We have experienced significant delays in certain raw materials and components, but we have largely been able to mitigate the impact of these delays on our consolidated results of operations. We continue to identify and qualify alternative sources to mitigate risk associated with single or sole sources of supply, and we may choose to purchase certain materials in safety stock where we have supply chain continuity concerns. We have experienced and we may continue to experience disruptions to our supply chains, which could materially affect our ability to timely manufacture and distribute our products and could also have a significant impact on the Company’s consolidated net revenue, results of operations, and cash flows during fiscal 2024 and beyond.
We also experienced material and supply chain inflation during the three and six months ended March 31, 2024, as further discussed in our Operations Review. The material and supply chain inflation experienced during the three and six months ended March 31, 2024 was less significant than the impact during the three and six months ended March 31, 2023. Pricing actions and supply chain productivity initiatives have mitigated and are expected to continue to mitigate some of these inflationary pressures, but we may not be successful in fully offsetting these incremental costs, which could have a significant impact on the Company’s consolidated results of operations and cash flows during fiscal 2024 and beyond.
For additional information regarding supply chain, inflation, and other risks, see Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2023, as filed with the SEC on November 15, 2023.
Divestiture
On February 1, 2023, the Company completed the divestiture of its historical Batesville reportable operating segment (“Batesville”) to BL Memorial Partners, LLC, a Delaware limited liability company owned by funds affiliated with LongRange Capital, L.P., for $761.5, including an $11.5 subordinated note.
This divestiture represented a strategic shift in Hillenbrand’s business and qualified as a discontinued operation. Unless otherwise noted, amounts presented in Management’s Discussion and Analysis are for continuing operations only.
The Company is providing, and will continue to provide, certain transition services to Batesville for applicable fees that are not material to the Company’s financial position. The transition services vary in duration depending upon the type of service provided.
Acquisitions
Acquisition of Schenck Process Food and Performance Materials Business
On September 1, 2023, the Company completed the acquisition of the Schenck Process Food and Performance Materials (“FPM”) business, a portfolio company of Blackstone, for total aggregate consideration of $763.3, including cash acquired, and is subject to certain customary post-closing adjustments, using available borrowings under its multi-currency revolving credit facility (the “Facility”). Headquartered in Kansas City, Missouri, FPM specializes in the design, manufacturing, and service of feeding, filtration, baking, and material handling technologies and systems that are highly complementary to the equipment and solutions offered in our Advanced Process Solutions reportable operating segment. The results of FPM since the date of acquisition are included in the Advanced Process Solutions reportable operating segment.
Acquisition of Peerless Food Equipment
On December 1, 2022, the Company completed the acquisition of the Peerless Food Equipment division (“Peerless”) of Illinois Tool Works Inc. for a purchase price of $59.2, net of certain customary post-closing adjustments and including cash acquired, using available borrowings under the Facility. Headquartered in Sidney, Ohio, Peerless is a premier supplier of industrial food processing equipment. The results of Peerless since the date of acquisition are included in the Advanced Process Solutions reportable operating segment.
Acquisition of LINXIS Group SAS
On October 6, 2022, the Company completed the acquisition of LINXIS Group SAS (“Linxis”) from IBERIS INTERNATIONAL S.À R.L, an affiliate of IK Partners, and additional sellers (collectively, the “Sellers”). As a result of the acquisition, the Company acquired from the Sellers all of the issued and outstanding securities of Linxis, and Linxis became a wholly owned subsidiary of the Company for total aggregate consideration of $590.8 (€596.2) in cash, reflecting an approximate enterprise value of $566.8 (€572.0) plus cash acquired at closing. The Company used available borrowings under the Facility to fund this acquisition. The results of Linxis since the date of acquisition are included in the Advanced Process Solutions reportable operating segment.
Restructuring
During the three months ended March 31, 2024, the Company announced a Program to reduce costs and improve operational efficiency within the Molding Technology Solutions reportable operating segment. The Company expects that substantially all of these costs, which are primarily severance costs, will result in future cash expenditures, and we anticipate the majority of these cash expenditures to be paid in the next twelve months.
OPERATING PERFORMANCE MEASURES
The following discussion compares our results for the three and six months ended March 31, 2024, to the same periods in 2023. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years refer to fiscal years. We begin the discussion at a consolidated level and then provide separate detail about Advanced Process Solutions, Molding Technology Solutions, and Corporate. These results of operations are prepared in accordance with GAAP.
We also provide certain non-GAAP operating performance measures. These non-GAAP financial measures are referred to as “adjusted” measures and primarily exclude expenses associated with business acquisition, divestiture, and integration costs, restructuring and restructuring-related charges, pension settlement charges, and inventory step-up charges. The related income tax impact for all of these items is also excluded. The measures also exclude certain tax items related to acquisitions and divestitures, the revaluation of deferred tax balances resulting from fluctuations in currency exchange rates and non-routine changes in tax rates for certain foreign jurisdictions, and the impact that the Molding Technology Solutions reportable operating segment’s loss carryforward attributes have on tax provisions related to the imposition of tax on Global Intangible Low-Taxed Income (“GILTI”) earned by certain foreign subsidiaries, the Foreign Derived Intangible Income Deduction (“FDII”), and the Base Erosion and Anti-Abuse Tax (“BEAT”).
Non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.
We use this non-GAAP information internally to measure operating segment performance and make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of our ongoing operating results. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by items such as the above excluded items. We believe this information provides a higher degree of transparency.
An important non-GAAP financial measure that we use is adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”). A part of Hillenbrand’s strategy is to selectively acquire companies that we believe can benefit from the Hillenbrand Operating Model (“HOM”) to spur faster and more profitable growth. Given that strategy, it is a natural consequence to incur related expenses, such as amortization from acquired intangible assets and additional interest expense from debt-funded acquisitions. Accordingly, we use adjusted EBITDA, among other measures, to monitor our business performance. Adjusted EBITDA is not a recognized term under GAAP and therefore does not purport to be an alternative to net income. Further, the Company’s measure of adjusted EBITDA may not be comparable to similarly titled measures of other companies.
Another important operational measure used is backlog. Backlog is not a term recognized under GAAP; however, it is a common measurement used in industries with extended lead times for order fulfillment (long-term contracts), like those in which our reportable operating segments compete. Backlog represents the amount of net revenue that we expect to realize on contracts awarded to our reportable operating segments. For purposes of calculating backlog, 100% of estimated net revenue attributable to consolidated subsidiaries is included. Backlog includes expected net revenue from large systems and equipment, as well as aftermarket parts, components, and service. The length of time that projects remain in backlog can span from days for aftermarket parts or service to approximately 18 to 24 months for larger system sales within the Advanced Process Solutions reportable operating segment. The majority of the backlog within the Molding Technology Solutions reportable operating segment is expected to be fulfilled within the next twelve months. Backlog includes expected net revenue from the remaining portion of firm orders not yet completed, as well as net revenue from change orders to the extent that they are reasonably expected to be realized. We include in backlog the full contract award, including awards subject to further customer approvals, which we expect to result in net revenue in future periods. In accordance with industry practice, our contracts may include provisions for cancellation, termination, or suspension at the discretion of the customer.
We expect that future net revenue associated with our reportable operating segments will be influenced by order backlog because of the lead time involved in fulfilling engineered-to-order equipment for customers. Although backlog can be an indicator of future net revenue, it does not include projects and parts orders that are booked and shipped within the same quarter. The timing of order placement, size, extent of customization, and customer delivery dates can create fluctuations in backlog and net revenue. Net revenue attributable to backlog may also be affected by foreign exchange fluctuations for orders denominated in currencies other than U.S. dollars.
We calculate the foreign currency impact on net revenue, gross profit, operating expenses, backlog, consolidated net income, and adjusted EBITDA in order to better measure the comparability of results between periods. We calculate the foreign currency impact by translating current year results at prior year foreign exchange rates. This information is provided because exchange rates can distort the underlying change in these metrics, either positively or negatively. The cost structure for Corporate is generally not significantly impacted by the fluctuation in foreign exchange rates, and we do not disclose the foreign currency impact in the Operations Review section below where the impact is not significant.
See page 41 for a reco
nciliation
of adjusted EBITDA to consolidated net income,
the most directly comparable GAAP measure. We use other non-GAAP
financial measures in certain other instances and include information reconciling such non-GAAP financial measures to the respective most directly comparable GAAP measures. Given that backlog is an operational measure and that the Company’s methodology for calculating backlog does not meet the definition of a non-GAAP financial measure, as that term is defined by the SEC, a quantitative reconciliation is not required or provided.
CRITICAL ACCOUNTING ESTIMATES
For the three and six months ended March 31, 2024, there were no significant changes to our critical accounting estimates as outlined in our Annual Report on Form 10-K for the year ended September 30, 2023, filed with the SEC on November 15, 2023.
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net revenue
increased $94.4 (14%).
•
Advanced Process Solutions net revenue increased $128.7 (30%), primarily driven by the impact of the FPM acquisition ($126.0), higher aftermarket parts and service net revenue, and favorable pricing, partially offset by a decrease in capital equipment volumes. Foreign currency impact improved net revenue by 1%.
•
Molding Technology Solutions net revenue decreased $34.3 (13%), primarily driven by a decrease in injection molding equipment volumes.
Gross profit
increased $24.6 (11%) and gross profit margin decreased 80 basis points to 31.9%. On an adjusted basis, which excluded business acquisition, divestiture, and integration costs, restructuring and restructuring-related charges and inventory step-up charges, adjusted gross profit increased $33.1 (15%), and adjusted gross profit margin improved 30 basis points to 33.4%.
•
Advanced Process Solutions gross profit increased $48.6 (32%), primarily driven by the impact of the FPM acquisition and favorable pricing, partially offset by cost inflation and lower volume. Foreign currency impact improved gross profit by 1%. Gross profit margin improved 70 basis points to 35.6%, primarily driven by favorable pricing, partially offset by cost inflation.
Advanced Process Solutions gross profit included inventory step-up (adjustments) charges related to acquisitions (($0.9) in 2024 and $3.1 in 2023). Excluding this non-recurring item, adjusted gross profit increased $45.0 (29%) and adjusted gross profit margin decreased 20 basis points to 35.4%.
•
Molding Technology Solutions gross profit decreased $24.0 (32%) primarily driven by a decrease in volume, an increase in restructuring and restructuring-related charges, and cost inflation, partially offset by favorable product mix. Gross profit margin decreased 610 basis points to 23.0%, primarily driven by an increase in restructuring and restructuring-related charges and cost inflation, partially offset by favorable product mix.
Molding Technology Solutions gross profit included restructuring and restructuring-related charges of $12.0 in 2024. Excluding these charges, adjusted gross profit decreased $12.0 (16%) and adjusted gross profit margin decreased 80 basis points to 28.3%.
Operating expenses
increased $41.9 (30%), primarily driven by acquisitions, cost inflation, higher restructuring and restructuring-related charges, an increase in business acquisition, divestiture, and integration costs, and other non-recurring costs in the current year related to a discrete commercial dispute stemming from a customer contract entered into prior to the acquisition of the Molding Technology Solutions reportable operating segment, partially offset by cost containment and lower variable compensation. Foreign currency impact increased operating expenses by 1%. Operating expenses as a percentage of net revenue increased by 290 basis points to 23.1%. Operating expenses included the following items:
Business acquisition, divestiture, and integration costs
$
9.1
$
7.3
Restructuring and restructuring-related charges
13.3
0.6
Other non-recurring costs related to a discrete commercial dispute
6.1
—
On an adjusted basis, which excludes business acquisition, divestiture, and integration costs, restructuring and restructuring-related charges, and other non-recurring costs related to the discrete commercial dispute described above, operating expenses increased $21.3 (16%). Adjusted operating expenses as a percentage of net revenue increased 50 basis points to 19.5%.
Amortization expense
increased $5.9 (30%) primarily driven by the impact of acquisitions in the prior fiscal year.
Interest expense, net
increased $12.2 (66%), primarily due to increased borrowing for acquisitions in the prior fiscal year. See Note 9 of Part I, Item 1 of this Quarterly Report on Form 10-Q for a discussion of borrowing activity.
The effective tax rate
was 32.8% in 2024 compared to 50.0% in 2023.
The decrease in the effective tax rate was primarily driven by a decrease in the tax accrual on unrepatriated earnings, a favorable currency fluctuation affecting the valuation of certain deferred tax liabilities, and a non-recurring prior year tax, partially offset by a reduced discrete tax benefit for equity compensation as compared to the prior period.
The adjusted effective tax rate was 28.1% in 2024 compared to 33.5% in 2023. The adjusted effective income tax rate excluded the tax effect of the following items:
•
The revaluation of deferred tax balances as a result of foreign currency fluctuations ($0.4 benefit in 2024 and $0.1 expense in 2023)
•
Change in the assertion with regard to foreign unremitted earnings as a result of the divestiture of Batesville ($4.8 expense in 2023)
•
The impact of tax loss carryforwards within the Molding Technology Solutions reportable operating segment on the net domestic taxes on foreign earnings ($0.2 expense in 2023)
•
Adjustments previously discussed within this section, such as business acquisition, divestiture, and integration costs
($17.4
benefit in 2024 and $7.4 benefit in 2023).
Six Months Ended March 31, 2024 Compared to Six Months Ended March 31, 2023
Net revenue
increased $212.0 (16%), which included favorable foreign currency impact (1%).
•
Advanced Process Solutions net revenue increased $284.2 (34%), primarily driven by the impact of acquisitions ($275.5), favorable pricing, and higher aftermarket parts and service net revenue, partially offset by a decrease in capital equipment volumes. Foreign currency impact improved net revenue by 2%.
•
Molding Technology Solutions net revenue decreased $72.2 (14%), primarily driven by a decrease in injection molding equipment volumes.
Gross profit
increased $68.0 (16%), which included favorable foreign currency impact (1%). Gross profit margin was flat compared to the prior year at 32.2%. On an adjusted basis, which excluded inventory step-up charges related to acquisitions and restructuring and restructuring-related charges
, adjusted gross profit increased $69.7 (16%), and adjusted gross profit margin was flat compared to the prior year at 33.0%.
•
Advanced Process Solutions gross profit increased $104.1 (37%), primarily driven by the impact of acquisitions, favorable pricing, and favorable product mix, partially offset by cost inflation and a decrease in volume. Foreign currency impact improved gross profit by 2%. Gross profit margin improved 70 basis points to 34.5% primarily driven by favorable pricing and favorable product mix, partially offset by cost inflation.
Advanced Process Solutions gross profit included inventory step-up charges related to acquisitions ($0.6 in 2024 and $11.1 in 2023).
Excluding these charges, adjusted gross profit increased $93.7 (32%) and adjusted gross profit margin decreased 60 basis points to 34.6%.
•
Molding Technology Solutions gross profit decreased $36.1 (24%), primarily driven by a decrease in volume, an increase in restructuring and restructuring-related charges, and cost inflation, partially offset by favorable product mix.
Gross profit margin decreased 350 basis points to 26.0%, primarily driven by restructuring and restructuring-related charges and cost inflation, partially offset by favorable product mix.
Molding Technology Solutions gross profit included restructuring and restructuring-related charges of $12.1 in 2024. Excluding these charges, adjusted gross profit decreased $24.1 (16%) and adjusted gross profit margin decreased 70 basis points to 28.8%.
Operating expenses
increased $61.9 (22%), primarily driven by acquisitions, cost inflation, an increase in restructuring and restructuring-related charges, and other non-recurring costs in the current year related to a discrete commercial dispute stemming from a customer contract entered into prior to the acquisition of the Molding Technology Solutions reportable operating segment, partially offset by lower variable compensation and a decrease in business acquisition, divestiture, and integration costs. Foreign currency impact decreased operating expenses by 2%. Operating expenses as a percentage of net revenue increased by 120 basis points to 21.8%. Operating expenses included the following items:
Six Months Ended March 31,
2024
2023
Business acquisition, divestiture, and integration costs
$
14.7
$
17.6
Restructuring and restructuring-related charges
13.8
1.6
Other non-recurring costs related to a discrete commercial dispute
6.1
—
On an adjusted basis,
which excludes business acquisition, divestiture, and integration costs, restructuring and restructuring-related charges, and
other non-recurring costs related to the discrete commercial dispute described above
, operating expenses increased $46.5 (18%). Adjusted operating expenses as a percentage of net revenue increased 30 basis points to 19.5%.
Amortization expense
increased $12.3 (32%) primarily driven by the impact of acquisitions.
Pension settlement charge
increased $8.3 due to lump-sum payments made from the Company’s U.S. pension plan to former employees who elected to receive such payments. See Note 10 of Part I, Item 1 of this Quarterly Report on Form 10-Q for further information on this pension settlement charge.
Interest expense, net
increased $20.5 (51%), primarily due to increased borrowing for acquisitions. See Note 9 of Part I, Item 1 of this Quarterly Report on Form 10-Q for a discussion of borrowing activity.
The effective tax rate
was 33.6% in 2024 compared to 34.2% in 2023. The decrease in the effective tax rate was primarily driven by a decrease in the tax accrual on unrepatriated earnings in the current period and a
non-recurring prior year tax
, partially offset by discrete tax benefits recognized in the prior period as a result of the approval of the incentive tax rate for certain operations located in China,
and a reduced discrete tax benefit for equity compensation as compared to the prior period.
The adjusted effective tax rate was 28.3% in 2024 compared to 29.6% in 2023. The adjusted effective income tax rate primarily excluded the tax effect of the following items:
•
The impact of Milacron tax loss carryforwards on net domestic taxes on foreign earnings ($0.1 benefit in 2023)
•
Change in the assertion with regard to foreign unremitted earnings as a result of the divestiture of Batesville ($4.8 expense in 2023)
•
The revaluation of deferred and current tax balances as a result of an incentive tax rate awarded to certain China operations ($3.4 benefit in 2023)
•
The revaluation of deferred tax balances as a result of foreign currency fluctuations ($0.1 benefit in 2024 and $0.3 expense in 2023)
•
Adjustments previously discussed within this section ($28.0 benefit in 2024 and $18.6 benefit in 2023).
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net revenue
increased $128.7 (30%) primarily driven by the impact of the FPM acquisition ($126.0), higher aftermarket parts and service net revenue, and favorable pricing, partially offset by a decrease in capital equipment volumes. Foreign currency impact improved net revenue by 1%.
Order backlog increased $203.7 (12%) from $1,673.4 at March 31, 2023, to $1,877.1 at March 31, 2024. The increase in order backlog was primarily driven by acquisitions, partially offset by the execution of existing backlog. Foreign currency impact decreased order backlog by 1%. On a sequential basis, order backlog decreased $38.7 (2%) to $1,877.1 at March 31, 2024, down from $1,915.8 at December 31, 2023, primarily due to the impact of foreign currency.
Gross profit
increased $48.6 (32%) primarily driven by the impact of the FPM acquisition and favorable pricing, partially offset by cost inflation and lower volume. Foreign currency impact improved gross profit by 1%. Gross profit margin improved 70 basis points to 35.6%, primarily driven by favorable pricing, partially offset by cost inflation.
Advanced Process Solutions gross profit included inventory step-up (adjustments) charges related to acquisitions (($0.9) in 2024 and $3.1 in 2023). Excluding these non-recurring items, adjusted gross profit increased $45.0 (29%) and adjusted gross profit margin decreased 20 basis points to 35.4%.
Operating expenses
increased $22.0 (26%) primarily driven by the impact of acquisitions, cost inflation, and an increase in business acquisition, divestiture, and integration costs, partially offset by lower variable compensation. Foreign currency impact increased operating expenses by 1%. Operating expenses as a percentage of net revenue improved 70 basis points to 19.3%.
Operating expenses included business acquisition, divestiture, and integration costs ($3.1 in 2024 and $1.6 in 2023). Excluding these items, adjusted operating expenses increased $20.6 (24%) and adjusted operating expenses as a percentage of net revenue improved 80 basis points to 18.8%.
Amortization expense
increased $6.0 (55%) primarily driven by the impact of acquisitions in the prior fiscal year.
Six Months Ended March 31, 2024 Compared to Six Months Ended March 31, 2023
Net revenue
increased $284.2 (34%), primarily driven by the impact of acquisitions ($275.5), favorable pricing, and higher aftermarket parts and service net revenue, partially offset by a decrease in capital equipment volumes. Foreign currency impact improved net revenue by 2%.
Gross profit
increased $104.1 (37%), primarily driven by the impact of acquisitions, favorable pricing, and favorable product mix, partially offset by cost inflation and a decrease in volume. Foreign currency impact improved gross profit by 2%. Gross profit margin improved 70 basis points to 34.5%, primarily driven by favorable pricing and favorable product mix, partially offset by cost inflation.
Advanced Process Solutions gross profit included inventory step-up charges related to acquisitions ($0.6 in 2024 and $11.1 in 2023). Excluding these charges, adjusted gross profit increased $93.7 (32%) and adjusted gross profit margin decreased 60 basis points to 34.6%.
Operating expenses
increased $49.3 (30%), primarily due to the impact of acquisitions and cost inflation, partially offset by lower variable compensation. Foreign currency impact increased operating expenses by 2%. Operating expenses as a percentage of net revenue improved 60 basis points to 19.1%.
Operating expenses included business acquisition, divestiture, and integration costs ($6.6 in 2024 and $3.1 in 2023) and restructuring and restructuring-related charges ($0.4 in 2024 and $0.9 in 2023). Excluding these items, adjusted operating expenses increased $46.4 (29%) and adjusted operating expenses as a percentage of net revenue improved 70 basis points to 18.5%.
Amortization expense
increased $12.4 (59%) primarily driven by the impact of acquisitions in the prior fiscal year.
OPERATIONS REVIEW — Molding Technology Solutions
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Amount
% of Net
Revenue
Amount
% of Net
Revenue
Amount
% of Net
Revenue
Amount
% of Net
Revenue
Net revenue
$
226.1
100.0
$
260.4
100.0
$
431.1
100.0
$
503.3
100.0
Gross profit
51.9
23.0
75.9
29.1
112.2
26.0
148.3
29.5
Operating expenses
54.9
24.3
35.0
13.4
89.1
20.7
72.3
14.4
Amortization expense
8.8
8.9
17.6
17.7
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net revenue
decreased $34.3 (13%), primarily driven by a decrease in injection molding equipment volumes.
Order backlog decreased $68.4 (23%) from $298.2 at March 31, 2023, to $229.8 at March 31, 2024. The decrease in order backlog was primarily driven by the execution of existing backlog. On a sequential basis, order backlog decreased $1.8 (1%) to $229.8 at March 31, 2024, down from $231.6 at December 31, 2023.
Gross profit
decreased $24.0 (32%) primarily driven by a decrease in volume, an increase in restructuring and restructuring-related charges, and cost inflation, partially offset by favorable product mix. Gross profit margin decreased 610 basis points to 23.0%, primarily driven by an increase in restructuring and restructuring-related charges and cost inflation, partially offset by favorable product mix.
Molding Technology Solutions gross profit included restructuring and restructuring-related charges of $12.0 in 2024. Excluding these charges, adjusted gross profit decreased $12.0 (16%) and adjusted gross profit margin decreased 80 basis points to 28.3%.
Operating expenses
increased $19.9 (57%), primarily driven by an increase in restructuring and restructuring-related charges and other non-recurring costs in the current year related to a discrete commercial dispute stemming from a customer contract entered into prior to the acquisition of the Molding Technology Solutions reportable operating segment, partially offset by cost containment actions. Operating expense as a percentage of net revenue increased 1,090 basis points to 24.3%.
Operating expenses included restructuring and restructuring-related charges ($13.2 in 2024 and $0.5 in 2023) and other non-recurring costs related to the discrete commercial dispute described above of $6.1 in 2024. Excluding these charges, adjusted operating expenses increased $1.2 (4%) and adjusted operating expenses as a percentage of net revenue increased 250 basis points to 15.7%.
Six Months Ended March 31, 2024 Compared to Six Months Ended March 31, 2023
Net revenue
decreased $72.2 (14%), primarily driven by a decrease in injection molding equipment volumes.
Gross profit
decreased $36.1 (24%), primarily driven by a decrease in volume, an increase in restructuring and restructuring-related charges, and cost inflation, partially offset by favorable product mix. Gross profit margin decreased 350 basis points to 26.0%, primarily driven by restructuring and restructuring-related charges and cost inflation, partially offset by favorable product mix.
Molding Technology Solutions gross profit included restructuring and restructuring-related charges of $12.1 in 2024. Excluding these charges, adjusted gross profit decreased $24.1 (16%) and adjusted gross profit margin decreased 70 basis points to 28.8%.
Operating expenses
increased $16.8 (23%), primarily driven by an increase in restructuring and restructuring-related charges, other non-recurring costs in the current year related to a discrete commercial dispute stemming from a customer contract entered into prior to the acquisition of the Molding Technology Solutions reportable operating segment, and cost inflation, partially offset by a decrease in variable compensation and cost containment actions. Foreign currency impact increased operating expenses by 1%. Operating expense as a percentage of net revenue increased 630 basis points to 20.7%.
Operating expenses included business acquisition, divestiture, and integration costs of $1.4 in 2023, restructuring and restructuring related charges ($13.3 in 2024 and $0.6 in 2023), and other non-recurring costs related to the discrete commercial dispute described above of $6.1 in 2024. Excluding these items, adjusted operating expenses decreased $0.5 (1%) and adjusted operating expenses as a percentage of net revenue increased 230 basis points to 16.2%.
REVIEW OF CORPORATE EXPENSES
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Amount
% of Net Revenue
Amount
% of Net Revenue
Amount
% of Net Revenue
Amount
% of Net Revenue
Core operating expenses
$
12.3
1.6
$
12.7
1.8
$
26.8
1.7
$
26.1
1.9
Business acquisition, divestiture, and integration costs
6.0
0.8
5.7
0.8
8.1
0.5
13.1
1.0
Restructuring and restructuring-related charges
0.1
—
—
—
0.1
—
—
—
Operating expenses
$
18.4
2.4
$
18.4
2.6
$
35.0
2.2
$
39.2
2.9
Corporate operating expenses include the cost of providing management and administrative services to each reportable operating segment. These services include treasury management, human resources, legal, business development, information technology, tax compliance, procurement, sustainability, and other public company support functions such as internal audit, investor relations, and financial reporting. Corporate operating expenses also include costs related to business acquisition, divestiture, and integration, which we incur as a result of our strategy to grow through selective acquisitions. Core operating expenses primarily represent corporate operating expenses excluding costs related to business acquisition, divestiture, and integration costs and restructuring and restructuring-related charges.
Business acquisition, divestiture, and integration costs include legal, tax, accounting, and other advisory fees and due diligence costs associated with investigating opportunities (including acquisitions and divestitures) and integrating completed acquisitions (including severance).
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Operating expenses were flat compared to the prior year. Cost inflation in the current year was offset by cost containment actions. These expenses as a percentage of net revenue were 2.4%, an improvement of 20 basis points from the prior year.
Core operating expenses decreased $0.4 (3%), primarily driven by cost containment actions, partially offset by cost inflation. These expenses as a percentage of net revenue were 1.6%, an improvement of 20 basis points from the prior year.
Six Months Ended March 31, 2024 Compared to Six Months Ended March 31, 2023
Operating expenses decreased $4.2 (11%), primarily due to a decrease in business acquisition, divestiture, and integrations costs. These expenses as a percentage of net revenue were 2.2%, an improvement of 70 basis points from the prior year.
Core operating expenses increased $0.7 (3%). These expenses as a percentage of net revenue were 1.7%, an improvement of 20 basis points from the prior year.
The following is a reconciliation from consolidated net income, the most directly comparable GAAP operating performance measure, to our non-GAAP adjusted EBITDA from continuing operations.
Three Months Ended March 31,
Six Months Ended March 31,
2024
2023
2024
2023
Consolidated net income
$
8.6
$
463.5
$
27.8
$
511.3
Interest expense, net
30.8
18.6
60.6
40.1
Income tax expense
4.2
24.1
14.2
26.4
Depreciation and amortization
41.2
31.0
80.0
62.0
Consolidated EBITDA
84.8
537.2
182.6
639.8
(Income) loss from discontinued operations (net of income tax expense)
—
(439.4)
0.3
(460.4)
Pension settlement charge
(1)
—
—
8.3
—
Business acquisition, divestiture, and integration costs
(2)
9.1
7.2
14.7
17.9
Inventory step-up (adjustment) charges
(0.9)
3.1
0.6
11.1
Restructuring and restructuring-related charges
(3)
23.5
0.5
24.1
1.5
Other non-recurring costs related to a discrete commercial dispute
6.1
—
6.1
—
Adjusted EBITDA from continuing operations
$
122.6
$
108.6
$
236.7
$
209.9
(1)
The pension settlement charge during the six months ended March 31, 2024 was due to lump-sum payments made from the Company’s U.S. pension plan to former employees who elected to receive such payments.
(2)
Business acquisition, divestiture, and integration costs during the three and six months ended March 31, 2024, primarily included costs associated with the integration of recent acquisitions. Business acquisition, divestiture, and integration costs during the three and six months ended March 31, 2023, primarily included professional fees related to acquisitions and costs associated with the integration of recent acquisitions.
(3)
Restructuring and restructuring-related charges primarily included severance costs during the three and six months ended March 31, 2024 and 2023.
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Consolidated net income decreased $454.9 (98%) for the three months ended March 31, 2024, compared to the same period in fiscal 2023. The decrease was primarily driven by a decrease in total income from discontinued operations, an increase in restructuring and restructuring-related charges, cost inflation, lower volume, an increase in interest expense, depreciation and amortization, and other non-recurring costs in the current year related to a discrete commercial dispute stemming from a customer contract entered into prior to the acquisition of the Molding Technology Solutions reportable operating segment, partially offset by the impact of acquisitions, lower income taxes, favorable pricing, and cost containment.
Consolidated adjusted EBITDA from continuing operations increased $14.0 (13%) for the three months ended March 31, 2024, compared to the same period in fiscal 2023. The increase was primarily driven by the impact of acquisitions, favorable pricing, and cost containment, partially offset by cost inflation and lower volume.
Six Months Ended March 31, 2024 Compared to Six Months Ended March 31, 2023
Consolidated net income decreased $483.5 (95%) for the six months ended March 31, 2024, compared to the same period in 2023. The decrease was primarily driven by the increase in total income from discontinued operations, cost inflation, an increase in restructuring and restructuring-related charges, lower volume, an increase in interest expense, depreciation and amortization, and other non-recurring costs related to the discrete commercial dispute described above, partially offset by the impact of acquisitions, lower income taxes, favorable pricing, cost containment and favorable product mix.
Consolidated adjusted EBITDA from continuing operations increased $26.8 (13%) for the six months ended March 31, 2024, compared to the same period in 2023. The increase was primarily driven by the impact of acquisitions, favorable pricing, cost containment, and favorable product mix, partially offset by cost inflation and lower volume.
In this section, we discuss our ability to access cash to meet business needs. We discuss how we see cash flow being affected for the next twelve months and how we intend to use it. We describe actual results in generating and using cash by comparing the first six months of 2024 to the same period last year. Finally, we identify other significant matters that could affect liquidity on an ongoing basis.
Ability to Access Cash
Our debt financing has historically included revolving credit facilities, term loans, and long-term notes as part of our overall financing strategy. We regularly review and adjust the mix of fixed-rate and variable-rate debt within our capital structure in order to achieve a target range based on our financing strategy.
We have taken proactive measures to maintain financial flexibility within the landscape of various uncertainties. We believe the Company ended the quarter with and continues to have sufficient liquidity to operate in the current business environment.
As of March 31, 2024, we had $868.3 of borrowing capacity under the Facility, of which $500.5 was immediately available based on our most restrictive covenant. The available borrowing capacity reflects a reduction of $19.5 for outstanding letters of credit issued under the Facility. The Company may request an increase of up to $600.0 in the total borrowing capacity under the Facility, subject to approval of the lenders.
In the normal course of business, operating companies within our reportable operating segments provide to certain customers bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, we maintain adequate capacity to provide the guarantees. As of March 31, 2024, we had guarantee arrangements totaling $588.7, under which $361.1 was used for guarantees. These arrangements include the Amended L/G Facility Agreement under which unsecured letters of credit, bank guarantees, or other surety bonds may be issued. The Company may request an increase to the total capacity under the Amended L/G Facility Agreement by an additional €100.0, subject to approval of the lenders.
We have significant operations outside the U.S. We continue to assert that the basis differences in the majority of our foreign subsidiaries continue to be permanently reinvested outside of the U.S. We have recorded tax liabilities associated with distribution taxes on expected distributions of available cash and current earnings. The Company has made, and intends to continue to make, substantial investments in our businesses in foreign jurisdictions to support the ongoing development and growth of our international operations. As of March 31, 2024, we had a transition tax liability of $11.2 pursuant to the 2017 Tax Cuts and Jobs Act (the “Tax Act”). The cash at our foreign subsidiaries, including U.S. subsidiaries participating in non-U.S. cash pooling arrangements, totaled $185.1 at March 31, 2024. We continue to actively evaluate our global capital deployment and cash needs.
12-month Outlook
The Company is required to pay a transition tax on unremitted earnings of its foreign subsidiaries, resulting in an estimated liability of $11.2 recorded as of March 31, 2024. The transition tax liability is expected to be paid over the next two years.
On December 2, 2021, our Board of Directors authorized a new share repurchase program of up to $300.0, which replaced the previous $200.0 share repurchase program. The repurchase program has no expiration date but may be terminated by the Board of Directors at any time.
We had approximately $125.0 remaining for share repurchases under the existing authorization at March 31, 2024.
Our anticipated contribution to our defined benefit pension plans in fiscal 2024 is $10.9, of which $4.1 was made during the six months ended March 31, 2024. We will continue to monitor plan funding levels, performance of the assets within the plans, and overall economic activity, and we may make additional discretionary funding decisions based on the net impact of the above factors.
We currently expect to pay quarterly cash dividends of approximately $15.6 based on our outstanding common stock at March 31, 2024. We increased our quarterly dividend in 2024 to $0.2225 per common share from $0.2200 per common share paid in 2023.
We believe existing cash and cash equivalents, cash flows from operations, borrowings under existing arrangements, and the issuance of debt will be sufficient to fund our operating activities and cash commitments for investing and financing activities. Based on these factors, we believe our current liquidity position is sufficient and will continue to meet all of our financial commitments in the current business environment.
Cash Flows
Six Months Ended March 31,
2024
2023
Cash flows (used in) provided by:
Operating activities from continuing operations
$
(20.8)
$
44.7
Investing activities from continuing operations
(27.9)
38.5
Financing activities from continuing operations
46.2
5.4
Net cash flows from discontinued operations
(23.3)
(3.4)
Effect of exchange rates on cash and cash equivalents
0.8
(6.9)
Net cash flows
$
(25.0)
$
78.3
Operating Activities
Operating activities from continuing operations used $20.8 of cash during the six months ended March 31, 2024, and provided $44.7 of cash during the six months ended March 31, 2023, an $65.5 increase. The increase in operating cash flow used in continuing operations was primarily due to unfavorable timing of working capital requirements.
Working capital requirements for our reportable operating segments fluctuate and may continue to fluctuate in the future due primarily to the type of product and geography of customer projects in process at any point in time. Working capital needs are lower when advance payments from customers are more heavily weighted toward the beginning of the project. Conversely, working capital needs are higher when a larger portion of the cash is to be received in later stages of manufacturing.
Investing Activities
The $66.4 decrease in net cash flows from investing activities from continuing operations during the six months ended March 31, 2024, was primarily due to the proceeds received on the divestiture of Batesville, partially offset by the acquisitions of Linxis and Peerless, in the prior year.
Financing Activities
Cash provided by financing activities from continuing operations was largely impacted by net borrowing activity. Our general practice is to use available cash to pay down debt unless it is needed for an acquisition. Cash provided by financing activities from continuing operations during the six months ended March 31, 2024 was $46.2, primarily due to the proceeds from the $500.0 2024 Notes, partially offset by net repayments on the Facility of $399.9 and payment of dividends on common stock. Cash provided by financing activities from continuing operations for the six months ended March 31, 2023 was $5.4, primarily due to net borrowings on the Facility of $57.8 and the $200.0 draw on the term loan commitment, partially offset by repayment of the Series A Notes and payment of dividends on common stock.
We returned $31.2 to shareholders during the six months ended
March 31, 2024
in the form of quarterly dividends. We increased our quarterly dividend in fiscal 2024 to $0.2225 per common share from $0.2200 per common share paid during fiscal 2023.
Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities
Summarized financial information of Hillenbrand (the “Parent”) and our subsidiaries that are guarantors of our senior unsecured notes (the “Guarantor Subsidiaries”) is shown below on a combined basis as the “Obligor Group.” The Company’s senior unsecured notes are guaranteed by certain of our wholly-owned domestic subsidiaries and rank equally in right of payment with all of our existing and financial information of the Obligor Group. All intercompany balances and transactions between the Parent and Guarantor Subsidiaries have been eliminated and all information excludes subsidiaries that are not issuers or guarantors of our senior unsecured notes, including earnings from and investments in these entities.
March 31, 2024
September 30, 2023
Combined Balance Sheets Information:
Current assets
(1)
$
3,711.5
$
2,710.8
Non-current assets
5,722.7
3,533.3
Current liabilities
1,178.0
985.1
Non-current liabilities
1,930.2
1,583.5
Six Months Ended
March 31, 2024
Combined Statements of Operations Information:
Net revenue
(2)
$
386.4
Gross profit
104.6
Consolidated net income from continuing operations attributable to Obligors
83.1
Total loss from discontinued operations (net of income tax expense) attributable to Obligors
(0.3)
Net income attributable to Obligors
82.8
(1)
Current assets include intercompany receivables from non-guarantors o
f $2,784.3
as of March 31, 2024 and
$2,070.6 as
of September 30, 2023.
(2)
Net revenue includes intercompany sales with non-guarantors of
$5.1
for the six months ended March 31, 2024.
Recently Adopted and Issued Accounting Standards
For a summary of recently issued and adopted accounting standards applicable to us, see Item 1, Note 2 of Part I of this Form 10-Q.
Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
A full discussion of quantitative and qualitative disclosures about market risk may be found in Item 7A of our 2023 Form 10-K for the year ended September 30, 2023, filed with the SEC on November 15, 2023. There have been no material changes in this information since the filing of our 2023 Form 10-K.
Item 4.
CONTROLS AND PROCEDURES
Our management, with the participation of our President and Chief Executive Officer and our Senior Vice President and Chief Financial Officer (the “Certifying Officers”), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures as of the end of the period covered by this report are effective.
In the ordinary course of business, we review our system of internal control over financial reporting and update our systems and processes to improve such controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, automating manual processes, and updating existing systems.
There have been no changes in internal control over financial reporting identified in the evaluation for the quarter ended March 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
PART II — OTHER INFORMATION
Item 1.
LEGAL PROCEEDINGS
Information pertaining to legal proceedings can be found in Note 15 to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
Item 1A.
RISK FACTORS
For information regarding the risks we face, see the discussion under Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2023, filed with the SEC on November 15, 2023.
Item 5.
OTHER INFORMATION
(a) Effective April 26, 2024, the Company’s Board of Directors approved amendments to its Amended and Restated Code of By-Laws following the regular review of corporate governance matters performed by the Board’s Nominating / Corporate Governance Committee. Among other things, these By-Law amendments address the SEC’s recent adoption of universal proxy rules and related requirements, including to provide that a shareholder nomination will be deemed null and void if the nominating shareholder fails to comply with the universal proxy rules, require a shareholder to provide evidence of compliance with the universal proxy rules, limit the number of directors a shareholder may nominate to the number of directors to be elected at the applicable meeting, and address the color of proxy cards reserved for use by the Board. The By-Law amendments also include other technical, conforming, and clarifying changes.
The complete text of the Company’s By-Laws, as well as a marked copy of the By-Laws illustrating the changes made, are attached hereto as Exhibits 3.2 and 3.2(a). The foregoing description is a summary only, does not purport to be complete, and is qualified in its entirety by reference to the complete text of the By-Laws, which is attached as Exhibit 3.2 and incorporated herein by reference.
(c) Rule 10b5-1 Trading Plans
During the three months ended March 31, 2024, no director or officer of the Company
adopted
or
terminated
a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6.
EXHIBITS
The exhibits filed with this report are listed below. In reviewing any agreements included as exhibits to this report, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about us or the other parties to the agreements. The agreements may contain representations and warranties by the parties to the agreements, including us. Except where explicitly stated otherwise, these representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:
•
should not necessarily be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
•
may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
•
may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
•
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
Restated and Amended Articles of Incorporation of Hillenbrand, Inc., effective as of February 13, 2020 (Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed February 14, 2020)
Supplemental Indenture No. 11, dated as of February 14, 2024, by and among Hillenbrand, Inc., the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association (Incorporated by reference to Exhibit 4.2 to Current Report on Form 8-K filed February 14, 2024)
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101
The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, formatted in Inline XBRL: (i) Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Shareholders’ Equity, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
Exhibit 104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Insider Ownership of Hillenbrand, Inc.
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of Hillenbrand, Inc.
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)